BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17145580)

  • 1. [Place of neoadjuvant treatments in oesophageal cancers care].
    Créhange G; Lorchel F; Bosset JF
    Bull Cancer; 2006 Nov; 93(11):1107-13. PubMed ID: 17145580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophageal cancer: adjuvant therapy.
    Ku GY; Ilson DH
    Cancer J; 2007; 13(3):162-7. PubMed ID: 17620765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of neoadjuvant therapy for esophageal adenocarcinoma.
    Ku GY; Ilson DH
    Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant treatment of oesophageal adenocarcinoma.
    Robb WB; Naughton P; Walsh TN
    Minerva Chir; 2004 Oct; 59(5):461-70. PubMed ID: 15494673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative radiochemotherapy for resectable localised oesophageal cancer: a controversial strategy.
    Crehange G; Bonnetain F; Peignaux K; Truc G; Blanchard N; Rat P; Chauffert B; Ghiringhelli F; Maingon P
    Crit Rev Oncol Hematol; 2010 Sep; 75(3):235-42. PubMed ID: 20044267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Should adjuvant or neoadjuvant treatment be administered in esophageal cancer?].
    Bedenne L
    Ann Chir; 1997; 51(6):605-10. PubMed ID: 9406457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].
    Fu JH; Rong TH; Li XD; Hu Y; Ou W; Hu YH; Li Q
    Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative therapy in esophageal cancer.
    Ku GY; Ilson DH
    Clin Adv Hematol Oncol; 2008 May; 6(5):371-9. PubMed ID: 18516027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current status of neoadjuvant therapy for esophageal cancer.
    Lin D; Leichman L
    Semin Thorac Cardiovasc Surg; 2014; 26(2):102-9. PubMed ID: 25441001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of age in the radical treatment of oesophageal cancer with surgery or chemoradiotherapy: a prospective observational cohort study.
    Davies L; Lewis WG; Arnold DT; Escofet X; Blackshaw G; Gwynne S; Evans M; Roberts SA; Appadurai I; Crosby TD
    Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):578-85. PubMed ID: 20591633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma.
    Morgan MA; Lewis WG; Casbard A; Roberts SA; Adams R; Clark GW; Havard TJ; Crosby TD
    Br J Surg; 2009 Nov; 96(11):1300-7. PubMed ID: 19847875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neoadjuvant treatment in surgery of esophageal cancer].
    Launois B; Raoul JL; Leprise E; Meunier B
    Bull Acad Natl Med; 2000; 184(8):1703-13; discussion 1714. PubMed ID: 11471389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant strategies for the treatment of locally advanced esophageal cancer.
    Hyngstrom JR; Posner MC
    J Surg Oncol; 2010 Mar; 101(4):299-304. PubMed ID: 20187065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.
    Meredith KL; Weber JM; Turaga KK; Siegel EM; McLoughlin J; Hoffe S; Marcovalerio M; Shah N; Kelley S; Karl R
    Ann Surg Oncol; 2010 Apr; 17(4):1159-67. PubMed ID: 20140529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Elsaleh H; Farrell JJ; Crane CH
    J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
    [No Abstract]   [Full Text] [Related]  

  • 18. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
    Xi H; Baldus SE; Warnecke-Eberz U; Brabender J; Neiss S; Metzger R; Ling FC; Dienes HP; Bollschweiler E; Moenig S; Mueller RP; Hoelscher AH; Schneider PM
    Clin Cancer Res; 2005 Dec; 11(23):8341-7. PubMed ID: 16322294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neoadjuvant radiochemotherapy in the treatment of esophageal squamous carcinoma:Preliminary results in a series of 15 patients].
    Popescu I; Ionescu M; Ciurea S; Stănescu C; Gheorghe C; Anghel R; Croitoru A
    Chirurgia (Bucur); 2003; 98(6):499-508. PubMed ID: 15143606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neoadjuvant therapy in oesophageal cancer surgery].
    Imdahl A
    Zentralbl Chir; 2006 Apr; 131(2):105-9. PubMed ID: 16612775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.